- Home
- EOI vs PAHC Comparison
EOI vs PAHC Comparison
Compare EOI & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOI
- PAHC
- Stock Information
- Founded
- EOI 2004
- PAHC 1946
- Country
- EOI United States
- PAHC United States
- Employees
- EOI N/A
- PAHC N/A
- Industry
- EOI Finance/Investors Services
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- EOI Finance
- PAHC Health Care
- Exchange
- EOI Nasdaq
- PAHC Nasdaq
- Market Cap
- EOI 819.4M
- PAHC 968.3M
- IPO Year
- EOI N/A
- PAHC 2014
- Fundamental
- Price
- EOI $21.00
- PAHC $29.18
- Analyst Decision
- EOI
- PAHC Hold
- Analyst Count
- EOI 0
- PAHC 4
- Target Price
- EOI N/A
- PAHC $24.50
- AVG Volume (30 Days)
- EOI 83.6K
- PAHC 363.5K
- Earning Date
- EOI 01-01-0001
- PAHC 08-27-2025
- Dividend Yield
- EOI 7.19%
- PAHC 1.64%
- EPS Growth
- EOI N/A
- PAHC 140.17
- EPS
- EOI N/A
- PAHC 0.78
- Revenue
- EOI N/A
- PAHC $1,190,682,000.00
- Revenue This Year
- EOI N/A
- PAHC $28.13
- Revenue Next Year
- EOI N/A
- PAHC $13.11
- P/E Ratio
- EOI N/A
- PAHC $37.39
- Revenue Growth
- EOI N/A
- PAHC 19.12
- 52 Week Low
- EOI $14.36
- PAHC $16.16
- 52 Week High
- EOI $18.88
- PAHC $31.80
- Technical
- Relative Strength Index (RSI)
- EOI 63.00
- PAHC 57.55
- Support Level
- EOI $20.70
- PAHC $28.75
- Resistance Level
- EOI $20.91
- PAHC $30.50
- Average True Range (ATR)
- EOI 0.19
- PAHC 0.97
- MACD
- EOI -0.03
- PAHC -0.30
- Stochastic Oscillator
- EOI 88.64
- PAHC 14.10
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.